1Furlan AD,Brosseau L,Imamura M,et al.Massage for low back pain:a systematic review within the framework of the Cochrane collaboration back review group.Spine,2002,27:1896-1910.
2Hagen KB,Hide G.The Cochrane review of advice to stay active as a single treatment for low back pain and sciatica.Spine,2002,27:1736-1741.
3Rozenberg S,Delval C,Rezvani Y,et al.Bed rest or normal activity for patients with acute low back pain:a randomized controlled trial.Spine,2002,27:1487-1493.
4Brosseau L,Milne S,Kobinson V,et al.Efficacy of the transcutaneous electrical nerve stimulation for the treatment of chronic low back pain:a meta-analysis.Spine,2002,27:596-603.
5Deyo RA.Drug therapy for back pain:which drugs help which patients? Spine,1996,21:2840-2850.
6Cherkin DC,Wheeler KJ,Barlow W,et al.Medication use for low back pain in primary care.Spine,1998,23:607-614.
6VL Arvanian PJ, Horner FH, Gage LM. Chronic neurotrophin-3 strengthens synaptic connections to motoneurons in the neonatal rat. J Neurosci ,2003,23:8706-8712.
7Unger T J, Calderon GA, Bradley LC,et al. Selective deletion of BDNF in the ventromedial and dorsomedical hypothalamus of adult mice re- sults in hyperphagic behavior and obesity. J Neurosci ,2007,27 : 14265- 14274.
8Merighi AR, Bardoni C, Lossi SL,et al. Presynaptic functional trkB re- ceptors mediate the release of excitatory neurotransmitters from primary afferent terminals in lamina II ( substantia gelatinosa) of postnatal rat spinal cord. Dev Neurobio1,2008,68:457-475.
9Caporali A, Emanueli C. Cardiovascular actions of neurotrophins. Physiol Rev ,2009,89:279-308.
10McCoy MX,Tansey MG. TNF signaling inhibition in the CNS :implica- tions for normal brain function and neurodegenerative disease. J Neuroinflammation ,2008,5:45-57.
